|
Alternate Name(s): |
Aneuploidy testing, maternal cell contamination studies
|
|
Specimen Requirement: |
PRENATAL: Aneuploidy testing (QF-PCR and karyotype) or Aneuploidy and copy number testing (QF-PCR and karyotype/chromosomal microarray, as indicated): - Minimum 15mL amniotic fluid (>17 mL preferable) or 10 mg chorionic villi AND 2-4 mL EDTA maternal peripheral blood (to be included with all prenatal specimens).
PERINATAL: QF-PCR or QF-PCR/chromosomal microarray, as indicated: - 1.5 cm fetal or placental* tissue in sterile transport media AND 2-4 mL EDTA maternal peripheral blood, if possible. (*note: microarray will not be performed using placental tissue)
NEONATAL/INFANT: Aneuploidy testing (QF-PCR and Karyotype, if indicated): - 1-2 mL EDTA peripheral blood AND 1-2 mL Sodium Heparin peripheral blood. NOTE: if only one collection tube is possible, EDTA is preferred.
Maternal cell contamination studies (to complement aneuploidy testing of prenatal , perinatal or cord blood specimens): - 2.4 mL EDTA peripheral blood
|
|
Turnaround Time: |
Perinatal Samples, 8 weeks.
|
|
Additional Information: |
Mothers blood is used to rule out maternal cell contamination.
For any inquiries, please contact geneticsmailbox@hhsc.ca
Blood collection at Hamilton Health Sciences (HHS) and St. Joseph’s Healthcare Hamilton (SJHH) collection centers is available only for patients whose testing has been ordered by an HHS or SJHH provider. Patients should otherwise be directed to an appropriate community laboratory.
|
|
Method of Analysis: |
QF - PCR
|
|
Test was Last Updated: |
11/20/2026
|
|
Testing Laboratory: |
Clinical Genetics
|